https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-02-10 / Mol. Ther. 2009 Apr;17(4):697-706
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-02-10 / Mol. Ther. 2009 Apr;17(4):697-7062009-02-10 00:00:002019-02-15 09:21:52Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-02-03 / Cancer Res. 2009 Feb;69(4):1448-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-02-03 / Cancer Res. 2009 Feb;69(4):1448-582009-02-03 00:00:002019-02-15 08:51:31Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-31 / Cancer Immunol. Immunother. 2009 Aug;58(8):1175-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-31 / Cancer Immunol. Immunother. 2009 Aug;58(8):1175-842009-01-31 00:00:002019-02-15 09:21:51The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-28 / Liver Int. 2009 Apr;29(4):593-602
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-28 / Liver Int. 2009 Apr;29(4):593-6022009-01-28 00:00:002019-02-15 09:21:53Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-17 / Virus Res. 2009 Apr;141(1):13-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-17 / Virus Res. 2009 Apr;141(1):13-202009-01-17 00:00:002019-02-15 09:21:56Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Methods Mol. Biol. 2009;542:565-605
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Methods Mol. Biol. 2009;542:565-6052009-01-01 00:00:002021-11-15 17:03:01Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-18 / Neurol. Res. 2009 Feb;31(1):3-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-18 / Neurol. Res. 2009 Feb;31(1):3-102008-10-18 00:00:002019-02-15 09:00:15Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-322008-10-01 00:00:002021-11-15 17:03:44Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-19 / Mol. Ther. 2008 Nov;16(11):1883-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-19 / Mol. Ther. 2008 Nov;16(11):1883-902008-08-19 00:00:002019-02-15 09:21:57Recombinant Newcastle disease virus as a vaccine vector for cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int. J. Cancer 2008 Aug;123(3):493-92008-08-01 00:00:002019-02-15 09:22:02Oncolytic virotherapy as a personalized cancer vaccine
